{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:47:02Z","timestamp":1791175622143,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,23]]},"DOI":"10.7759\/cureus.39404","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:32:44Z","timestamp":1684866764000},"source":"Crossref","is-referenced-by-count":1,"title":["Unmasking Non-small Cell Lung Cancer: The Unusual Trail of Hip Pain and Skeletal Metastasis"],"prefix":"10.7759","author":[{"given":"Hamad","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoore","family":"Jannat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urooj","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noaman","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. Lung. (2020). https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/15-Lung-fact-sheet.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2014.12.006","article-title":"Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry","volume":"87","author":"Kocher F","year":"2015","unstructured":"Kocher F, Hilbe W, Seeber A, et al.. Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry. Lung Cancer. 2015, 87:193-200. 10.1016\/j.lungcan.2014.12.006","journal-title":"Lung Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel RL","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021, 71:7-33. 10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.1_suppl.137s","article-title":"Noninvasive staging of non-small cell lung cancer: a review of the current evidence","volume":"123","author":"Toloza EM","year":"2003","unstructured":"Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest. 2003, 123:137S-46S. 10.1378\/chest.123.1_suppl.137s","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2423051707","article-title":"Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases","volume":"242","author":"Mujoomdar A","year":"2007","unstructured":"Mujoomdar A, Austin JH, Malhotra R, Powell CA, Pearson GD, Shiau MC, Raftopoulos H. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. Radiology. 2007, 242:882-8. 10.1148\/radiol.2423051707","journal-title":"Radiology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2355","article-title":"Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Silvestri GA","year":"2013","unstructured":"Silvestri GA, Gonzalez AV, Jantz MA, et al.. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013, 143:e211S-50S. 10.1378\/chest.12-2355","journal-title":"Chest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2359","article-title":"Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Howington JA","year":"2013","unstructured":"Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013, 143:e278S-313S. 10.1378\/chest.12-2359","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3620","article-title":"The integration of radiotherapy with immunotherapy for the treatment of non-small cell lung cancer","volume":"24","author":"Ko EC","year":"2018","unstructured":"Ko EC, Raben D, Formenti SC. The integration of radiotherapy with immunotherapy for the treatment of non-small cell lung cancer. Clin Cancer Res. 2018, 24:5792-806. 10.1158\/1078-0432.CCR-17-3620","journal-title":"Clin Cancer Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199002223220802","article-title":"A randomized trial of surgery in the treatment of single metastases to the brain","volume":"322","author":"Patchell RA","year":"1990","unstructured":"Patchell RA, Tibbs PA, Walsh JW, et al.. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990, 322:494-500. 10.1056\/NEJM199002223220802","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2014-0128-RA","article-title":"Biomarkers in lung adenocarcinoma: a decade of progress","volume":"139","author":"Sholl LM","year":"2015","unstructured":"Sholl LM. Biomarkers in lung adenocarcinoma: a decade of progress. Arch Pathol Lab Med. 2015, 139:469-80. 10.5858\/arpa.2014-0128-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.06.028","article-title":"The IASLC lung cancer staging project: methodology and validation used in the development of proposals for revision of the stage classification of NSCLC in the forthcoming (eighth) edition of the tnm classification of lung cancer","volume":"11","author":"Detterbeck FC","year":"2016","unstructured":"Detterbeck FC, Chansky K, Groome P, et al.. The IASLC lung cancer staging project: methodology and validation used in the development of proposals for revision of the stage classification of NSCLC in the forthcoming (eighth) edition of the tnm classification of lung cancer. J Thorac Oncol. 2016, 11:1433-46. 10.1016\/j.jtho.2016.06.028","journal-title":"J Thorac Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.177","article-title":"Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data","volume":"23","author":"Hoang T","year":"2005","unstructured":"Hoang T, Xu R, Schiller JH, Bonomi P, Johnson DH. Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data. J Clin Oncol. 2005, 23:175-83. 10.1200\/JCO.2005.04.177","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880515)61:10<2083::aid-cncr2820611025>3.0.co;2-u","article-title":"Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter","volume":"61","author":"Takise A","year":"1988","unstructured":"Takise A, Kodama T, Shimosato Y, Watanabe S, Suemasu K. Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter. Cancer. 1988, 61:2083-8. 10.1002\/1097-0142(19880515)61:10&lt;2083::aid-cncr2820611025&gt;3.0.co;2-u","journal-title":"Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31826bb7b2","article-title":"Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib","volume":"7","author":"D'Angelo SP","year":"2012","unstructured":"D'Angelo SP, Janjigian YY, Ahye N, et al.. Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib. J Thorac Oncol. 2012, 7:1815-22. 10.1097\/JTO.0b013e31826bb7b2","journal-title":"J Thorac Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/158688-unmasking-non-small-cell-lung-cancer-the-unusual-trail-of-hip-pain-and-skeletal-metastasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:55Z","timestamp":1707508915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/158688-unmasking-non-small-cell-lung-cancer-the-unusual-trail-of-hip-pain-and-skeletal-metastasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.39404","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,23]]}}}